Regenxbio
Agent36Agent Readiness: 36/100. Below median. Measured by StartupHub.ai. Median 41.Trust86Data Trust: 86/100. Top 25%. Measured by StartupHub.ai. Median 61.Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
About
REGENXBIO is a clinical-stage biotechnology company focused on developing gene therapies using its proprietary NAV Technology Platform, which utilizes adeno-associated virus (AAV) vectors. The company aims to improve lives by delivering one-time treatments for rare and retinal diseases, as well as metabolic and neurodegenerative conditions. Their pipeline includes investigational therapies for Duchenne muscular dystrophy, MPS II, MPS I, and wet age-related macular degeneration.
Similar companies
A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Shares Drug Discovery, Clinical Trials
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Shares Biotech, MedTech
Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Shares Biotech, MedTech
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
Gene therapy company developing transformative treatments for severe genetic diseases.
Shares Biotech, MedTech
Key facts
- Website
- regenxbio.com
- Headquarters
- Rockville, United States
- Founded
- 2008
- Employees
- 396
- Total funding
- $180M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 19 May 2025 | Funding Round | $150M | |
| 21 Jan 2015 | Series C | $30M | Venrock Healthcare Capital Partners |
Tech stack
Detected on regenxbio.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- Bootstrap
- Analytics
- Google Tag Manager
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Regenxbio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Regenxbio is 86 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Regenxbio raised?
Regenxbio has raised a total of $180M in funding. The most recent round on record is Funding Round.
How many employees does Regenxbio have?
Regenxbio has approximately 396 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Regenxbio:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
